Charles Schwab’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Sell |
164,313
-3,789
| -2% | -$70.6K | ﹤0.01% | 2532 |
|
|
2025
Q1 | $3.05M | Buy |
168,102
+1,081
| +0.6% | +$19.6K | ﹤0.01% | 2474 |
|
|
2024
Q4 | $3.64M | Buy |
167,021
+1,092
| +0.7% | +$23.8K | ﹤0.01% | 2485 |
|
|
2024
Q3 | $4.54M | Buy |
165,929
+97,362
| +142% | +$2.67M | ﹤0.01% | 2422 |
|
|
2024
Q2 | $1.77M | Buy |
+68,567
| New | +$1.77M | ﹤0.01% | 2741 |
|
|
2023
Q3 | – | Sell |
-1,711
| Closed | -$20.7K | – | 3586 |
|
|
2023
Q2 | $20.7K | Hold |
1,711
| – | – | ﹤0.01% | 3555 |
|
|
2023
Q1 | $21.8K | Hold |
1,711
| – | – | ﹤0.01% | 3500 |
|
|
2022
Q4 | $10.8K | Hold |
1,711
| – | – | ﹤0.01% | 3526 |
|
|
2022
Q3 | $39K | Buy |
+1,711
| New | +$39K | ﹤0.01% | 3388 |
|
|
2022
Q2 | – | Sell |
-5,572
| Closed | -$259K | – | 3564 |
|
|
2022
Q1 | $259K | Buy |
5,572
+381
| +7% | +$17.7K | ﹤0.01% | 3255 |
|
|
2021
Q4 | $368K | Hold |
5,191
| – | – | ﹤0.01% | 3242 |
|
|
2021
Q3 | $605K | Buy |
5,191
+517
| +11% | +$60.3K | ﹤0.01% | 3074 |
|
|
2021
Q2 | $732K | Buy |
4,674
+1,258
| +37% | +$197K | ﹤0.01% | 3037 |
|
|
2021
Q1 | $648K | Buy |
3,416
+239
| +8% | +$45.3K | ﹤0.01% | 2998 |
|
|
2020
Q4 | $399K | Hold |
3,177
| – | – | ﹤0.01% | 3060 |
|
|
2020
Q3 | $346K | Buy |
3,177
+400
| +14% | +$43.6K | ﹤0.01% | 2985 |
|
|
2020
Q2 | $334K | Sell |
2,777
-252
| -8% | -$30.3K | ﹤0.01% | 2993 |
|
|
2020
Q1 | $305K | Buy |
3,029
+1
| +0% | +$101 | ﹤0.01% | 2888 |
|
|
2019
Q4 | $735K | Hold |
3,028
| – | – | ﹤0.01% | 2692 |
|
|
2019
Q3 | $498K | Buy |
3,028
+328
| +12% | +$53.9K | ﹤0.01% | 2803 |
|
|
2019
Q2 | $638K | Buy |
2,700
+700
| +35% | +$165K | ﹤0.01% | 2713 |
|
|
2019
Q1 | $527K | Buy |
2,000
+1,190
| +147% | +$314K | ﹤0.01% | 2745 |
|
|
2018
Q4 | $74K | Buy |
+810
| New | +$74K | ﹤0.01% | 3110 |
|